Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Knud A. Møller"'
2
Untersuchungen über die Wirkung des Theophyllins auf die Chlorid- und Wasserausscheidung bei Kaninchen mit artifizieller chronischer tubulärer Nephritis
Autor: Knud O. Møller., Johannes Frandsen
Publikováno v: Acta Medica Scandinavica. 68:385-402
Zusammenfassung. 1) Wie fruher von Frandsen gezeigt, ist es moglich, durch wiederholte Injektionen kleiner Mengen K2Cr2O7 bei Kaninchen eine chronische tubulare Nephritis hervorzurufen, wobei sich die Glomeruli durch die histologische Untersuchung so
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae918822b8445cc33ec122edd942ad10
https://doi.org/10.1111/j.0954-6820.1928.tb12363.x
Zobrazit plný text záznamu
8
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: A randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C)
Autor: Søren Cold, Susanne Møller, Preben Philip, Claus Kamby, Knud Aage Møller, Erik H Jacobsen, Bent Ejlertsen, Disa Jensen, Marianne Ewertz, Jørn Andersen
Publikováno v: Andersen, J, Kamby, C, Ejlertsen, B, Cold, S, Ewertz, M, Jacobsen, E H, Philip, P, Møller, K A, Jensen, D & Møller, S 2008, ' Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C) ', Acta Oncologica, vol. 47, no. 4, pp. 718-24 . https://doi.org/10.1080/02841860802014882
Andersen, J, Kamby, C, Ejlertsen, B, Cold, S, Ewertz, M, Jacobsen, E H, Philip, P, Møller, K A, Jensen, D & Møller, S 2008, ' Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate : a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C) ', Acta Oncologica, vol. 47, no. 4, pp. 718-724 . https://doi.org/10.1080/02841860802014882
Udgivelsesdato: 2008 From January 1, 1990 to December 31, 1994, DBCG conducted a randomised trial in 1 615 postmenopausal women with operable, high-risk, receptor-positive or -unknown breast cancer. The patients were after surgery randomised to Tamox
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b5da53625a10027afe115029a604de
https://doi.org/10.1080/02841860802014882
Zobrazit plný text záznamu
9
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age
Autor: Per Dombernowsky, Henning T. Mouridsen, Knud Aage Møller, Ib Jarle Christensen, Lars Bastholt, Jørn Andersen, Martin Andersson, Carsten Rose, Claus Kamby, Pia Munkholm
Publikováno v: Breast Cancer Research and Treatment. 61:103-110
The efficacy of combined endocrine therapy with tamoxifen (TAM), aminoglutethimide (AG), and hydrocortisone (H) or tamoxifen and fluoxymesterone (FLU) was evaluated against treatment with tamoxifen alone in 311 patients above 65 years of age with a f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3daf3c4de775b1c8f581c61b4606d4d
https://doi.org/10.1023/a:1006460925986
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje